on-q pressur continu drive neg revis top
bottom line outlook organ growth acceler
margin assumpt come
solid quarter weaker guid avano report revenu roughli in-
line mse impli pt organ growth momentum
bottom line ep beat mse primarili lower oper
expens oper margin vs mse manag re-affirmed
expect organ growth acceler consist view
would low point growth improv throughout year
rais cc revenu growth pt midpoint although adjust
 impli avano target low end previou
guidanc cc growth ep adjust downward midpoint
acut pain headwind continu longer
expect discuss pleas see exhibit full
reconcili result vs mse
dig deeper guidanc manag rais cc revenu guidanc
yet underli basi impli guid
low end origin rang avano announc complet
neom acqusit annual busi contribut
bp cc growth year manag announc new
acquisit summit annual busi add cc
growth year estim term outlook segment
chronic hum along consist msd growth chronic
avano deliv organ growth quarter
manag express confid segment continu
deliv msd growth especi neom provid compani
lead posit qualiti nutrit feed devic chronic
also remain signific compon avano grow intern
busi manag note expect corpor intern
growth acceler hsd year note avano face
challeng chronic comp therefor model step-
lsd growth quarter though maintain estim
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
organ growth chronic year
on-q recoveri delay notabl chang commentari center
pain manag manag expect on-q issu
persist remaind year despit commentari
resolut could begin materi back half delay
recoveri appear demand suppli driven estim
on-q growth remain neg lsd-msd rang
repres moder neg hsd
turn posit
intervent pain coolief continu grow doubl digit though
recent propos impli reimburs unlik play
catalyst manag hope drive growth
next year estim coolief
growth impli revenu year
earli thought manag yet provid guidanc
indic underli growth like acceler next year chronic
continu deliv consist msd growth on-q turn posit
manag expect bp oper margin expans model
bp year sens avano deliv anoth bp
oper margin expans next year model om
prior expect larg delay on-q recoveri
organ growth estim come prior
prior flow
ep previous
remain underweight pt certain aspect today call
encourag chronic growth consist oper margin
expans on-track manag confirm execut cost
save target thu far year howev lower underli growth due
longer-last on-q headwind remain issu lower price target
reflect new ebitda estim discount
smid med-tech coverag could becom posit avano case
demonstr on-q recoveri upsid intern growth number driven
chronic manag highlight point strength greater
reimburs coolief drive growth attract
valuat execut deal corpak-lik profil near-term
headwind keep us cautiou
transform price
transform price upsid busi improv capit
upsid busi improv capit
deriv base case scenario price target reflect
ev ebitda estim discount smid med-tech
coverag given lower organ growth partial off-set signific
market reward avano accret deal near-term recoveri on-q
avano execut larg acquisit drive growth earn accret
growth restructur plan progress accord plan
transform proce estim high avano return msd
organ growth follow on-q suppli headwind path
toward oper margin improv move forward plan
restructur prove challeng medic devic sale growth low/mid
singl digit restructur initi yield expect benefit lead
lower earn level
transform price
believ investor alreadi price
major benefit associ cost
transform risk near-term
revenu headwind make upsid mid-
includ continu headwind within
on-q busi normal flu season
competit pressur within oral care
materi upsid requir
limit visibl time divestitur
 ip leav avano signific capac
execut deal execut deal
corpak-lik profil drive bull case
deploy half deal capac could drive
ebitda accret ep accret
everi cost save dis-
synergi worth ep
growth on-q drive pt corpor
restructur execut
risk achiev price
signific near-term recoveri on-q pain
avano execut larg accret
million except ep
sale
sale
sale
sale
sale
sale
sale
sale
dollar million except per share data
good sold
dollar million except per share data
cash equival
current defer incom tax
properti plant equip net
accumul comprehens incom loss
dollar million except per share data
depreci amort
share-bas compens charg
provis loss account receiv inventori
net loss asset disposit
chang oper work capit
prepaid expens asset
acquisit invest
disposit properti
invest activ
chang net invest
financ activ
effect exchang rate chang
begin period
end period
